Navigation Links
Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011

FARMINGDALE, N.Y., May 4, 2011 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), a medical device company that designs, manufactures, and markets innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications, announced today that it will present at the MDB Capital Bright Lights Conference on Wednesday, May 11, 2011 at the Le Parker Meridien Hotel in New York City.  Michael A. McManus, Jr., President and Chief Executive Officer, will address the conference at 11:30 AM Eastern time to discuss the Company's business strategy and historical financial performance.

Bright Lights is the only conference of its kind with an exclusive focus on publicly-traded companies with market changing intellectual property (IP).

Misonix was selected from MDB's 2011 group of "Best and Brightest" small-cap companies; a group that is advancing some of today's most innovative and market-leading IP.  Misonix is one of the 40 public companies ranking in the 90th percentile for its respective technology leadership from more than 1,500 small-cap companies with granted U.S. patents, as rated by PatentVest, MDB's proprietary IP business intelligence platform.

To learn more about the event, please visit:

About MDB Capital Group

MDB Capital Group, LLC is an institutional research and investment banking firm focusing exclusively on small and micro-cap companies possessing market changing, disruptive intellectual property.  For more information on MDB Capital Group, visit:

About PatentVest

PatenVest® is a proprietary intellectual property (IP) business intelligence platform developed by MDB Capital Group. PatentVest quantifies the appropriate valuation of IP and enables the emergence of IP as an investible asset class. For more information on PatentVest visit:

About Misonix:

Misonix, Inc. designs, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $3 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications.  Additional information is available on the Company's Web site at

Investor Relations Contact:
Kevin McGrath, Cameron Associates, Inc.

SOURCE Misonix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Misonix Exhibits at Annual APTA-CSM Meeting
2. Misonix Announces New Distribution Agreement for Colombia
3. Misonix Announces Change in Distribution of BoneScalpel™ Bone Cutting System in the U.S.
4. Misonix to Present at the ROTH Capital Growth Stock Conference on March 15, 2011
5. Misonix Reports Second Quarter and Six Months Fiscal 2011 Financial Results
6. Misonix Announces Completion of Product Registrations in Key Latin American Markets
7. Misonix Schedules Second Quarter 2011 Financial Results Conference Call; February 9, 2011 at 4:30 p.m. Eastern
8. Misonix to Present at Sidoti & Company 2011 Micro Cap Conference
9. Misonix Announces Achievement of Contract Vendor Status With Select Medical Corporation
10. Misonix Previews New OsteoSculpt® Ultrasonic Bone Scalpel
11. Misonix Reports First Quarter Fiscal 2011 Financial Results
Post Your Comments:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... , June 24, 2016 The Academy ... of recommendations that would allow biopharmaceutical companies ... with entities that make formulary and coverage decisions, a ... "value" of new medicines. The recommendations address ... not appear on the drug label, a prohibition that ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... PawPaws ... a new product that was developed to enhance the health of felines. The formula ... , The two main herbs in the PawPaws Cat Kidney Support Supplement ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can ... Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey ... cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):